Table 2.
Quantification of SARS-CoV-2 RNA and genome sequencing
| Pat. ID | CT numeric bronchial samples | Viral load bronchial samples (cp/ml) | Conjunctiva | CT numeric conjunctiva | Viral load conjunctiva (cp/ml) | Vitreous body | CT numeric vitreous body | Viral load vitreous body (cp/ml) | Pangolin lineage | GISAID accession ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 30.39 | 156,813 | - | NA | NA | + | 36.22 | 3015 | NA | NA |
| 2 | 13.63 | 4,361,119,298 | - | NA | NA | - | NA | NA | B.1.160 | EPI_ISL_1751567 |
| 3 | 29.99 | 205,648 | - | NA | NA | - | NA | NA | B.1.177 | EPI_ISL_1751564 |
| 4 | 30.97 | 105,842 | - | NA | NA | - | NA | NA | NA | NA |
| 5 | 30.89 | 111,739 | - | NA | NA | - | NA | NA | NA | NA |
| 6 | 18.35 | 548,819,077 | - | NA | NA | - | NA | NA | B.1.258 | EPI_ISL_2095237 |
| 7 | 27.36 | 1,222,593 | - | NA | NA | - | NA | NA | B.1.177 | EPI_ISL_1752145 |
| 8 | 34.59 | 9101 | - | NA | NA | - | NA | NA | NA | NA |
| 9 | 36.65 | 2253 | - | NA | NA | - | NA | NA | NA | NA |
| 10 | 16.33 | 2,157,884,964 | + | 31.21 | 89,952 | + | 32.75 | 31,674 | B.1.1.141 | EPI_ISL_1752180 |
| 11 | 31.89 | 56,735 | - | NA | NA | - | NA | NA | NA | NA |
| 12 | 21.44 | 67,587,939 | + | 32.03 | 51,599 | + | 27.14 | 1,419,189 | B.1.177 | EPI_ISL_1752212 |
| 13 | 26.72 | 1,886,556 | + | 31.29 | 85,205 | + | 32.04 | 51,250 | B.1.177 | EPI_ISL_1751846 |
| 14 | 24.00 | 11,921,143 | + | 36.69 | 2193 | + | 41.59 | 71 | B.1.177 | EPI_ISL_1751511 |
| 15 | 16.64 | 1,748,952,174 | + | 30.20 | 178,365 | - | NA | NA | B.1.1.7 | EPI_ISL_2094844 |
| 16 | 28.50 | 379,585 | + | 33.50 | 40,391 | - | NA | NA | B.1.1.7 | EPI_ISL_2095010 |
| 17 | 32.32 | 42,391 | + | 41.50 | 76 | - | NA | NA | B.1.160 | EPI_ISL_1752358 |
| 18 | 35.89 | 3771 | + | 37.20 | 1537 | - | NA | NA | B.1.1.7 | EPI_ISL_2095002 |
| 19 | 17.44 | 1,016,934,884 | + | 34.11 | 12,600 | + | 36.36 | 2761 | NA | NA |
| 20 | 26.75 | 1,848,583 | + | 32.78 | 43,556 | - | NA | NA | B.1.1.7 | EPI_ISL_2094634 |
CT cycle threshold, NA not applicable